The effect of caffeine reduction on sleep quality and well-being in persons with HIV. (Q44340526)

2 December 2017

title

The effect of caffeine reduction on sleep quality and well-being in persons with HIV. (English)

1 reference

2 December 2017

H Michael Dreher

1

1 reference

2 December 2017

publication date

1 March 2003

1 reference

Journal of Psychosomatic Research

2 December 2017

published in

1 reference

2 December 2017

volume

54

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

191-198

1 reference

Comparative stimulant and diuretic actions of caffeine and theobromine in man.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Effect of a lipid-rich fraction from boiled coffee on serum cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Survival advantage among patients with breast cancer diagnosed at 45 to 49 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Sleep in men and women infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

The fatigue experience for women with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Exploring the complexity of sleep disturbances in persons with HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Correlates of sleep quality in persons with HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Lentiviral infection, immune response peptides and sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Pathologic features of the liver in acquired immune deficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Interactions of the human immunodeficiency virus and the hepatotropic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Sleep quality in people with HIV disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: development, reliability, and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

The correlation of epidemiological variables.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Patterns of personal health practice: men and women in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Factors predictive of alcohol consumption in a representative sample of French male teenagers: a five-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Relationship between sleepiness and general health status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Caffeine reinforcement: the role of withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Effects of breakfast and caffeine on performance and mood in the late morning and after lunch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Biochemical validation of self-reported caffeine consumption during caffeine fading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900472-5

10.1016/S0022-3999(02)00472-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference